{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:02:05Z","timestamp":1789718525343,"version":"4.0.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"DOI":"10.7759\/cureus.116464","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:05:55Z","timestamp":1789715155000},"source":"Crossref","is-referenced-by-count":0,"title":["Inner Ear Schwannoma Treated With Intratympanic Gentamicin for Recurrent M\u00e9ni\u00e8re's Disease-Like Vertigo: A Case Report"],"prefix":"10.7759","author":[{"given":"Honoka","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimaru","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamori","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000001875","article-title":"Incidence of intralabyrinthine schwannoma: a population-based study within the United States","volume":"39","author":"Marinelli JP","year":"2018","unstructured":"Marinelli JP, Lohse CM, Carlson ML. Incidence of intralabyrinthine schwannoma: a population-based study within the United States. Otol Neurotol. 2018, 39:1191-4. 10.1097\/MAO.0000000000001875","journal-title":"Otol Neurotol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000000415","article-title":"Clinical presentation of intralabyrinthine schwannomas: a multicenter study of 110 cases","volume":"35","author":"Dubernard X","year":"2014","unstructured":"Dubernard X, Somers T, Veros K, et al.. Clinical presentation of intralabyrinthine schwannomas: a multicenter study of 110 cases. Otol Neurotol. 2014, 35:1641-9. 10.1097\/MAO.0000000000000415","journal-title":"Otol Neurotol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1678731","article-title":"Intralabyrinthine schwannomas: disease presentation, tumor management, and hearing rehabilitation","volume":"80","author":"Choudhury B","year":"2019","unstructured":"Choudhury B, Carlson ML, Jethanamest D. Intralabyrinthine schwannomas: disease presentation, tumor management, and hearing rehabilitation. J Neurol Surg B Skull Base. 2019, 80:196-202. 10.1055\/s-0039-1678731","journal-title":"J Neurol Surg B Skull Base"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2020.623078","article-title":"Endolymphatic hydrops in patients with intralabyrinthine schwannomas","volume":"7","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Li F, Dai C, Wang W. Endolymphatic hydrops in patients with intralabyrinthine schwannomas. Front Surg. 2020, 7:623078. 10.3389\/fsurg.2020.623078","journal-title":"Front Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1043452","article-title":"Case report: concurrent intravestibular schwannoma mimicking M\u00e9ni\u00e8re's disease and cochlear hydrops detected via delayed three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging","volume":"13","author":"Nishimura K","year":"2022","unstructured":"Nishimura K, Murofushi T, Hakuba N. Case report: concurrent intravestibular schwannoma mimicking M\u00e9ni\u00e8re's disease and cochlear hydrops detected via delayed three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging. Front Neurol. 2022, 13:1043452. 10.3389\/fneur.2022.1043452","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2021.09.011","article-title":"MRI characteristics of intralabyrinthine schwannoma on post-contrast 4\u00a0h-delayed 3D-FLAIR imaging","volume":"103","author":"Poillon G","year":"2022","unstructured":"Poillon G, Horion J, Daval M, et al.. MRI characteristics of intralabyrinthine schwannoma on post-contrast 4\u00a0h-delayed 3D-FLAIR imaging. Diagn Interv Imaging. 2022, 103:171-6. 10.1016\/j.diii.2021.09.011","journal-title":"Diagn Interv Imaging"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-06271-6","article-title":"MRI of endolymphatic hydrops in patients with intralabyrinthine schwannomas: a case-controlled study using non-enhanced T2-weighted images at 3\u00a0T","volume":"278","author":"Venkatasamy A","year":"2021","unstructured":"Venkatasamy A, Bretz P, Karol A, Karch-Georges A, Charpiot A, Veillon F. MRI of endolymphatic hydrops in patients with intralabyrinthine schwannomas: a case-controlled study using non-enhanced T2-weighted images at 3\u00a0T. Eur Arch Otorhinolaryngol. 2021, 278:1821-7. 10.1007\/s00405-020-06271-6","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01.mao.0000227663.79210.c1","article-title":"Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable M\u00e9ni\u00e8re's disease","volume":"27","author":"Horii A","year":"2006","unstructured":"Horii A, Saika T, Uno A, et al.. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable M\u00e9ni\u00e8re's disease. Otol Neurotol. 2006, 27:896-900. 10.1097\/01.mao.0000227663.79210.c1","journal-title":"Otol Neurotol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5152\/iao.2017.2772","article-title":"Intralabyrinthine vestibular schwannoma responsive to intratympanic gentamicin treatment","volume":"13","author":"Covelli E","year":"2017","unstructured":"Covelli E, Volpini L, Filippi C, Tarantini S, Marrone V, Monini S, Barbara M. Intralabyrinthine vestibular schwannoma responsive to intratympanic gentamicin treatment. J Int Adv Otol. 2017, 13:285-8. 10.5152\/iao.2017.2772","journal-title":"J Int Adv Otol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000002530","article-title":"A systematic review of interventions for balance dysfunction in patients with vestibular schwannoma","volume":"41","author":"Ojha S","year":"2020","unstructured":"Ojha S, Clamp PJ. A systematic review of interventions for balance dysfunction in patients with vestibular schwannoma. Otol Neurotol. 2020, 41:e295-303. 10.1097\/MAO.0000000000002530","journal-title":"Otol Neurotol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000001016","article-title":"Cochlear implantation in patients with intracochlear and intralabyrinthine schwannomas","volume":"37","author":"Carlson ML","year":"2016","unstructured":"Carlson ML, Neff BA, Sladen DP, Link MJ, Driscoll CL. Cochlear implantation in patients with intracochlear and intralabyrinthine schwannomas. Otol Neurotol. 2016, 37:647-53. 10.1097\/MAO.0000000000001016","journal-title":"Otol Neurotol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/lary.31422","article-title":"Cochlear implant outcomes in patients with intralabyrinthine schwannoma: a scoping review","volume":"134","author":"Wang K","year":"2024","unstructured":"Wang K, Gjini EK, Kooper-Johnson S, Cooper MI, Gallant C, Noonan KY. Cochlear implant outcomes in patients with intralabyrinthine schwannoma: a scoping review. Laryngoscope. 2024, 134:3910-20. 10.1002\/lary.31422","journal-title":"Laryngoscope"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2021.102984","article-title":"Management of vestibular dysfunction and hearing loss in intralabyrinthine schwannomas","volume":"42","author":"Totten DJ","year":"2021","unstructured":"Totten DJ, Manzoor NF, Perkins EL, Cass ND, Bennett ML, Haynes DS. Management of vestibular dysfunction and hearing loss in intralabyrinthine schwannomas. Am J Otolaryngol. 2021, 42:102984. 10.1016\/j.amjoto.2021.102984","journal-title":"Am J Otolaryngol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MAO.0000000000004363","article-title":"Revised classification of inner ear schwannomas","volume":"46","author":"Plontke SK","year":"2025","unstructured":"Plontke SK, Lloyd SK, Freeman SR, et al.. Revised classification of inner ear schwannomas. Otol Neurotol. 2025, 46:3-9. 10.1097\/MAO.0000000000004363","journal-title":"Otol Neurotol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/534207-inner-ear-schwannoma-treated-with-intratympanic-gentamicin-for-recurrent-mnires-disease-like-vertigo-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:05:56Z","timestamp":1789715156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/534207-inner-ear-schwannoma-treated-with-intratympanic-gentamicin-for-recurrent-mnires-disease-like-vertigo-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.116464","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}